# Dexpramipexole and Cimetidine Drug Drug Interaction (DDI)

> **NCT01536249** · PHASE1 · COMPLETED · sponsor: **Knopp Biosciences** · enrollment: 14 (actual)

## Conditions studied

- Amyotrophic Lateral Sclerosis

## Interventions

- **DRUG:** Dexpramipexole
- **DRUG:** Cimetidine plus Dexpramipexole

## Key facts

- **NCT ID:** NCT01536249
- **Lead sponsor:** Knopp Biosciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-03
- **Primary completion:** 2012-04
- **Final completion:** 2012-04
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2014-11-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01536249

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01536249, "Dexpramipexole and Cimetidine Drug Drug Interaction (DDI)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01536249. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*